Atlas Trials

Dose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly

Clinical trial NCT06309225 · RECRUITING

Trial details

NCT number
NCT06309225
Sponsor
Omar Mahmoud
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Oropharynx CancerFrailty
Start date
2025-05-15
Primary completion
2026-09-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.